← Back to Search

Fast Track for Sleep Apnea

N/A
Waitlist Available
Led By Sachin R Pendharkar, MD, MSc
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year after treatment initiation
Awards & highlights

Study Summary

Access to medical care for patients with breathing disorders during sleep is a major problem for Canadians. Recently, there has been increasing interest in how health care providers who are not physicians can help to improve access to medical care for these patients, but it is unclear whether patients with severe sleep-disordered breathing who receive care from these non-physician providers have the same response to treatment as patients who receive care from physicians. Since these severe have a high risk of developing cardiac and respiratory complications and of being hospitalized, an initiative to improve access such as the use of non-physician providers could be of great benefit to individual patients and the health care system. The objectives of this project are: to determine whether patients with severe breathing disorders during sleep have the same response to treatment when cared for by non-physician health care providers (respiratory therapists) as they do when cared for by physicians; to determine the effects of non-physician health care provider treatment to patient access; to determine health care utilization and related costs associated with non-physician health care provider treatment.

Eligible Conditions
  • Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year after treatment initiation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year after treatment initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Adherence to positive airway pressure (PAP) therapy
Change in daytime sleepiness
Change in disease specific health-related quality of life
+7 more

Trial Design

2Treatment groups
Active Control
Group I: Fast TrackActive Control1 Intervention
In the "Fast Track" arm, an ACP will perform the initial assessment and will determine the management plan with the patient.
Group II: Standard ManagementActive Control1 Intervention
Patients in the "Standard Management" arm will be assessed without any interventions.Patients will be assessed by a sleep respirologist and follow a management plan that is determined by the sleep physician and patient. This plan may involve polysomnography or the initiation of PAP therapy. If further testing is ordered, follow-up may occur with the physician or with an ACP, at the physician's discretion. For patients initiating PAP therapy, the decision to delegate follow-up to an ACP will be left up to the physician, as the intent of this study is to observe real-world practice and not to change the management of individual patients.

Find a Location

Who is running the clinical trial?

The Lung AssociationUNKNOWN
1 Previous Clinical Trials
30 Total Patients Enrolled
University of CalgaryLead Sponsor
792 Previous Clinical Trials
868,990 Total Patients Enrolled
1 Trials studying Sleep Apnea
12 Patients Enrolled for Sleep Apnea
Sachin R Pendharkar, MD, MScPrincipal InvestigatorUniversity of Calgary

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~16 spots leftby Apr 2025